Abstract:Tumor imaging tools with high specificity and sensitivity are needed to aid the boundary recognition in solid tumor diagnosis and surgical resection. In this study, we developed a near infra-red (NIR) probe (P6) for in vitro/in vivo tumor imaging on the basis of the dual strategy of cancer cell targeting and stimulus-dependent activation. The selective imaging capacity towards cancer cells of P6 was thoroughly investigated, and the potential mechanisms of endocytosis were preliminary explored. Methods: GSH-activated biotin labelled NIR probe (P6) was designed, synthesized and characterized. The GSH responsive properties were systematically illustrated through UV-vis, fluorescent tests and LC-MS analysis. In vitro fluorescent imaging of probe P6 was collected in various living cancer cell lines (i.e. SW480, HGC-27, H460, BxPC-3, KHOS) and normal cell lines (i.e. BEAS-2B, HLF-1, THP1) under confocal laser scanning microscopy. Probe P6 was further applied to image primary human cancer cells which were freshly isolated from the peritoneal carcinoma and rectal cancer patients. Serial sections of human tumor tissues were collected and sent for H&E (hematoxylin-eosin) staining and P6 imaging. Live fluorescent and photoacoustic imaging were used to investigate the in vivo imaging of P6 in both tumor and normal tissues in HGC 27 and KHOS xenograft model. Results: Probe P6 could be recognized and transported into cancer cells by tumor specific biotin receptors and efficiently be triggered by GSH to release fluorophore 4. In fact, the cellular uptake of P6 could be partially blocked by the addition of free biotin. Furthermore, probe P6 could image various cancer cell lines, as well as primary cancer cells, exhibiting a ten-fold increase in fluorescence intensity over normal cells. In freshly dissected cancer tissues, P6 fluorescent imaging distinguished the cancerous area under confocal laser scanning microscopy, which was exact the same area as indicated by H&E staining. We also found that P6 exhibited superior selectivity against cancer tissues by local injection. Conclusion: In this study, we developed a dual-modal NIR probe P6 with enhanced cellular uptake into cancer cells and environmental stimulus triggered fluorescence. Our strategy provided a novel insight into the development of imaging tools that could be potentially used for fluorescent image-guided cancer boundary recognition and possibly cancer diagnosis.

Intracellular Dual Fluorescent Lightup Bioprobes for Image-Guided Photodynamic Cancer Therapy.

Intracellular Fluorescent Light-Up Bioprobes with Different Morphology for Image-Guided Photothermal Cancer Therapy

A near-infrared bioprobe with aggregation-induced emission feature for in vitro photodynamic therapy

NAD(P)H-triggered Probe for Dual-Modal Imaging During Energy Metabolism and Novel Strategy of Enhanced Photothermal Therapy in Tumor.

Aggregation-Induced Bioprobe for Plasma Membrane-Specific Imaging and Photodynamic Cancer Cell Ablation

A Ph-Activatable And Aniline-Substituted Photosensitizer For Near-Infrared Cancer Theranostics

Microenvironment-triggered dual-activation of a photosensitizer- fluorophore conjugate for tumor specific imaging and photodynamic therapy

A photoactivatable theranostic probe for simultaneous oxidative stress-triggered multi-color cellular imaging and photodynamic therapy

Light-Induced Translocation of a Conjugated Polyelectrolyte in Cells: From Fluorescent Probe to Anticancer Agent

Glutathione-activated biotin-targeted dual-modal imaging probe with improved PDT/PTT synergistic therapy

A cancer cell and lysosome dual-targeted photosensitizer for fluorescence imaging and photodynamic therapy

Multifunctional Organic Fluorescent Probe with Aggregation-Induced Emission Characteristics: Ultrafast Tumor Monitoring, Two-Photon Imaging, and Image-Guide Photodynamic Therapy

Lipid Droplet‐Targetable Fluorescence Guided Photodynamic Therapy of Cancer Cells with an Activatable AIE‐Active Fluorescent Probe for Hydrogen Peroxide

The Golden Touch by Light: A Finely Engineered Luminogen Empowering High Photoactivatable and Photodynamic Efficiency for Cancer Phototheranostics

GSH Activated Biotin-tagged Near-Infrared Probe for Efficient Cancer Imaging.

A tumor-targeting fluorescent probe for ratiometric imaging of pH and improving PDT/PTT synergistic therapy

Multiple functional nanoprobe for contrast-enhanced bimodal cellular imaging and targeted therapy.

Diketopyrrolopyrrole-based Multifunctional Ratiometric Fluorescent Probe and Γ-Glutamyltranspeptidase-triggered Activatable Photosensitizer for Tumor Therapy

Dual Ph-Responsive Polypeptide Nanoprobes for Lysosomes Enhanced Bioimaging and Tumor Photothermal Therapy under 1064 Nm Irradiation

Activatable Photodynamic Therapy with Therapeutic Effect Prediction Based on a Self-correction Upconversion Nanoprobe.

Selective Imaging and Cancer Cell Death Via Ph Switchable Near-Infrared Fluorescence and Photothermal Effects.